Application of Nanoparticles in Tumour Targeted Drug Delivery and Vaccine

Author:

Tu Yuhan,Yao Zhiang,Yang Wenjing,Tao Shanhui,Li Bin,Wang Yun,Su Zhijian,Li Shijun

Abstract

Cancer is a major cause of death worldwide, and nearly 1 in 6 deaths each year is caused by cancer. Traditional cancer treatment strategies cannot completely solve cancer recurrence and metastasis. With the development of nanotechnology, the study of nanoparticles (NPs) has gradually become a hotspot of medical research. NPs have various advantages. NPs exploit the enhanced permeability and retention (EPR) of tumour cells to achieve targeted drug delivery and can be retained in tumours long-term. NPs can be used as a powerful design platform for vaccines as well as immunization enhancers. Liposomes, as organic nanomaterials, are widely used in the preparation of nanodrugs and vaccines. Currently, most of the anticancer drugs that have been approved and entered clinical practice are prepared from lipid materials. However, the current clinical conversion rate of NPs is still extremely low, and the transition of NPs from the laboratory to clinical practice is still a substantial challenge. In this paper, we review the in vivo targeted delivery methods, material characteristics of NPs and the application of NPs in vaccine preparation. The application of nanoliposomes is also emphasized. Furthermore, the challenges and limitations of NPs are briefly discussed.

Publisher

Frontiers Media SA

Subject

Electrical and Electronic Engineering,Computer Science Applications,Biomedical Engineering,Atomic and Molecular Physics, and Optics,Electronic, Optical and Magnetic Materials

Reference203 articles.

1. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development;Abdulla;Pathogens,2021

2. High Affinity Restricts the Localization and Tumor Penetration of Single-Chain Fv Antibody Molecules;Adams;Cancer Res.,2001

3. Emerging Advances in Cationic Liposomal Cancer Nanovaccines: Opportunities and Challenges;Ahmad;Immunotherapy,2021

4. Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines;Alfagih;Pharmaceutics,2021

5. Application of Nanoparticles in Cancer Therapy with an Emphasis on Cell Cycle;Almanghadim;Cell Biol. Int.,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3